Literature DB >> 16390901

Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis.

Peter de Jonge1, Johan Ormel, Rob H S van den Brink, Joost P van Melle, Titia A Spijkerman, Astrid Kuijper, Dirk J van Veldhuisen, Maarten P van den Berg, Adriaan Honig, Harry J G M Crijns, Aart H Schene.   

Abstract

OBJECTIVE: The reporting of depressive symptoms following myocardial infarction may be confounded by complaints originating from the myocardial infarction. Therefore, it is difficult to estimate the effects of post-myocardial infarction depression and its treatment on cardiovascular prognosis. The authors' goal was to study the relationship between depressive symptom dimensions following myocardial infarction and both somatic health status and prospective cardiovascular prognosis.
METHOD: In two studies of myocardial infarction patients (N=494 and 1,972), the Beck Depression Inventory was used to determine the dimensional structure of depressive symptoms following myocardial infarction. Three symptom dimensions-somatic/affective, cognitive/affective, and appetitive-were compared with baseline left ventricular ejection fraction, Charlson comorbidity index, Killip class, and previous myocardial infarction. The relationship between depressive symptom dimensions and prospective cardiovascular mortality and cardiac-related readmissions was also examined (mean follow-up duration=2.5 years).
RESULTS: Somatic/affective symptoms were associated with poor health status (left ventricular ejection fraction, Charlson comorbidity index, Killip class, and previous myocardial infarction) and predicted cardiovascular mortality and cardiac events. Cognitive/affective symptoms were only marginally associated with somatic health status and not with cardiovascular death and cardiac events. Appetitive symptoms were related to somatic health status but did not predict cardiovascular death or cardiac events.
CONCLUSIONS: Somatic/affective depressive symptoms following myocardial infarction were confounded by somatic health status yet were prospectively associated with cardiac prognosis even after somatic health status was controlled. Cognitive/affective depressive symptoms were only marginally related to health status and not to cardiac prognosis. These findings suggest that treatment of depression following myocardial infarction might improve cardiovascular prognosis when it reduces somatic/affective symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16390901     DOI: 10.1176/appi.ajp.163.1.138

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  65 in total

1.  Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromes.

Authors:  Jonathan A Shaffer; Donald Edmondson; William F Chaplin; Joseph E Schwartz; Daichi Shimbo; Matthew M Burg; Nina Rieckmann; Karina W Davidson
Journal:  Psychosom Med       Date:  2011-06-02       Impact factor: 4.312

Review 2.  Is there a high-risk subtype of depression in patients with coronary heart disease?

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

3.  Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.

Authors:  Karina W Davidson; Matthew M Burg; Ian M Kronish; Daichi Shimbo; Lucia Dettenborn; Roxana Mehran; David Vorchheimer; Lynn Clemow; Joseph E Schwartz; Francois Lespérance; Nina Rieckmann
Journal:  Arch Gen Psychiatry       Date:  2010-05

Review 4.  Depression in people with coronary heart disease: prognostic significance and mechanisms.

Authors:  Chris Dickens
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

5.  Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors.

Authors:  Joost P van Melle; Peter de Jonge; Maarten P van den Berg; Harm J Pot; Dirk J van Veldhuisen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Depressive symptoms in patients with obstructive sleep apnea: biological mechanistic pathways.

Authors:  Diana A Chirinos; Indira Gurubhagavatula; Preston Broderick; Julio A Chirinos; Karen Teff; Thomas Wadden; Greg Maislin; Hassam Saif; Jesse Chittams; Caitlin Cassidy; Alexandra L Hanlon; Allan I Pack
Journal:  J Behav Med       Date:  2017-06-21

7.  Genetic predictors of depressive symptoms in cardiac patients.

Authors:  Jeanne M McCaffery; Qing Ling Duan; Nancy Frasure-Smith; Amina Barhdadi; Francois Lespérance; Pierre Théroux; Guy A Rouleau; Marie-Pierre Dubé
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

Review 8.  AAFP guideline for the detection and management of post-myocardial infarction depression.

Authors: 
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

9.  Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study.

Authors:  James C Jackson; Pratik P Pandharipande; Timothy D Girard; Nathan E Brummel; Jennifer L Thompson; Christopher G Hughes; Brenda T Pun; Eduard E Vasilevskis; Alessandro Morandi; Ayumi K Shintani; Ramona O Hopkins; Gordon R Bernard; Robert S Dittus; E Wesley Ely
Journal:  Lancet Respir Med       Date:  2014-04-07       Impact factor: 30.700

10.  A pilot study exploring the effects of a 12-week t'ai chi intervention on somatic symptoms of depression in patients with heart failure.

Authors:  Laura S Redwine; Ming Tsuang; Anna Rusiewicz; Ines Pandzic; Stephanie Cammarata; Thomas Rutledge; Suzi Hong; Sarah Linke; Paul J Mills
Journal:  J Altern Complement Med       Date:  2012-07-30       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.